Lung Ultrasound in Comparison With C.T in Covid-19
Sponsor
Sohag University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05158803
Collaborator
(none)
200
35.9
Study Details
Study Description
Brief Summary
investigate the diagnostic ability of thoracic ultrasound in suspicious COVID-19 infection and/or COVID-19 pneumonia. Also, to compare its findings to CT and follow up these findings.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
ultrasound and C.T will be assessed in acute presentation of Covid 19 patients and then those patients will be reassessed again after 1 month by lung ultrasound and C.T and if ultrasound will show the same efficacy of diagnosis or not
Study Design
Study Type:
Observational
Anticipated Enrollment
:
200 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Can Lung Ultrasound Play a Competitive Role With Computed Tomography in Diagnosis and Follow up of Covid-19 Patients?
Anticipated Study Start Date
:
Jan 1, 2022
Anticipated Primary Completion Date
:
Jan 1, 2024
Anticipated Study Completion Date
:
Dec 30, 2024
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| covid 19 in acute phase
|
Radiation: ultrasound and C.T
lung ultrasound in comparison to C.T
|
| covid 19 follow up
|
Radiation: ultrasound and C.T
lung ultrasound in comparison to C.T
|
Outcome Measures
Primary Outcome Measures
- diagnostic ability of thoracic ultrasound for diagnosis and follow up of covid19 patients [after 1 month of acute presentation]
compare lung ultrasound with C.T finding of covid 19 patients
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 95 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
- all cases of covid 19 patients
Exclusion Criteria:
- all other causes of consolidation ,ground glass fibrosis or collapse findings of C.T and ultrasound
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Sohag University
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Esraa Mohamed Amin,
Sohag university,
Sohag University
ClinicalTrials.gov Identifier:
NCT05158803
Other Study ID Numbers:
- Soh-Med-21-12-16
First Posted:
Dec 15, 2021
Last Update Posted:
Dec 15, 2021
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms: